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1. Introduction
   Stress, anxiety and depression are of prevalent and highly 
comorbid psychiatric conditions in the world, which are 
defined as a negative emotional experience and associated 
with biochemical, cognitive, behavioral and psychological 
changes. Herbal medicine has been widely used among 
sufferers of mood and anxiety disorders since antiquity[1,2].
   Depression is a common, chronic and recurring disorder 
with some properties like low cognitive and emotional 
reactions that imposes high expanses to patients and 
remedial system[3]. Chronic and recurring nature of 
depression has changed it to a resistant disorder against 
treatment[4]. Depression is a common disorder with 
prevalence of about 15% during the lifecycle, and today 
it is considered as the main reason of disability around 
the world and is in the fourth rank among ten main 
reasons of world load of diseases. It is predicted that after 
cardiovascular disease, depression prevalence will be 
increased to the second greatest risk of morbidity, causing 
a significant socioeconomic burden[5].
   Anxiety is resonant situation of emotional stimulation 
that contains the fear or worry feeling. Unlike the 
patients with fear, the patients with worry feeling often 
understand danger source vaguely. Studies show that 
among the behavioral problems, anxiety has the highest 
frequency, and studying factors affecting students’ anxiety 
demonstrates that physical factors, factors related to growth 
periods, social, family and affective factors have significant 
effect on their anxiety[6]. About 500 million individuals 
in the world suffer from anxiety disorder[7]. Anxiety has 
various mental and physical signs including palpitation, 
cramp, perspire, asthma, nausea, provocation, urination, 
feeling of fear and stress, failure to encounter position, 
uncertainty about future, expectation of sorrow occurrence, 
inability of concentration and night sleeplessness[8].
   Due to side effects and destructive effects of some 
chemical drugs, many patients prefer herbal medicines 
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to treat diseases[1]. From a sample size of more than 2 000 
subjects interviewed during 1997-1998, it was estimated 
that more than half of those suffered anxiety attacks, 
and more than 54% of those with severe depression had 
used medicinal plants or other complementary therapies 
during the previous 12 months to treat their disorders. The 
inpatients hospitalized for acute care of various psychiatric 
disorders in North America also showed that 44% had 
used herbal medicines during the previous 12 months for 
psychiatric purposes[9].
   About 25% of all drugs prescribed by doctors in the 
current medicine are obtained from herbs in different forms. 
Some of them are produced directly from plant extracts and 
others are produced artificially to provide effects similar to 
herbal drugs[10].
   Over the last two centuries, with the isolation of active 
constituents, such as morphine from opium poppies, 
recognition of psychoactive plants has significantly 
advanced[1], and various kinds of researches on herbal 
medicine have increased in recent years with more than 
50% increase in the literature over 5 years up to 2008[11].
   Although not all commonly used phytomedicines are 
safe, most of herbal products available as “over-the-
counter” psychotropic medicines are fairly safe, with fewer 
adverse effects in comparison to conventional drugs such as 
antidepressants[12,13]. Furthermore, in some cases research 
in medicinal plants resulted in discovery of highly effective 
drugs such as development of opiate anesthetics, aspirin, 
digitoxin and taxol[14]. Many medicinal plants have been 
recognized for the treatment of specific disorders, but some 
of them are grown in some specific areas and are used 
for thousands of years without being entered in books or 
recognized by scientists. Therefore, in the present study, 
we tried to present the effect of most important medicinal 
plants on two important highly comorbid psychiatric 
conditions-anxiety and depression. Although there are key 
review papers in the area of medicinal plants and psychiatry 
disorders, either have they covered the area in a relatively 
cursory manner or focused on a specific plant medicine such 
as Hypericum perforatum (H. perforatum)[15]. While research 
is increasing in the area of herbal psychopharmacology 
to date, no comprehensive review exists exploring the use 
of botanicals in the treatment of depression and anxiety 
disorders. These are highly comorbid, and as psychotropic 
herbal medicines exert an array of psychopharmacological 
actions.
   A search was done on electronic databases such as Web 
of Science, MEDLINE (PubMed), Cochrane Library, CINAHL and 
Google Scholar to review the evidence of herbal medicines 
with antidepressant and anxiolytic activities. Databases 
were searched for both in vivo and in vitro data on major 
herbal medicines used commonly in psychotherapy, using 
the search terms of “anxiety” or “depression” combined 
with the search terms “medicinal plants” or “botanical 
medicine” or “herbal medicine”, in addition to hand-
searching the literature.
2. Pathogenesis of depression
   In the last decades, the pathogenesis of depression has 
focused on monoamine impairment, lowering of monoamine 
production, or secondary messenger dysfunction[16]. In 
recent years, added attention has also focused on the role 
of neuro‐endocrinological abnormalities such as cortisol 
excess, as well as cytokine or steroidal alterations, changes 
in GABAergic and/or glutamatergic transmission, impaired 
endogenous opioid function, and abnormal circadian 
rhythm[16,17].
3. Pathogenesis of anxiety
   The pathophysiology of anxiety is not as clear as 
depression and still needs to be established. However, 
current evidence indicates that the pathophysiology 
of anxiety includes neurobiology abnormalities of 
noradrenergic, serotonergic, GABAergic and glutamatergic 
transmission[18]. Involvement of these systems is reflected 
in the efficacy of benzodiazepines, selective serotonin 
reuptake inhibitors as well as selective serotonin and 
noradrenalin reuptake inhibitors in the treatment of 
anxiety[19].
4. Mechanism of action herbal medicines
   The antidepressant mechanisms of action of herbal 
medicines, in most cases, are not as clear as with synthetic 
drugs, having a multitude of biological effects on reuptake 
and receptor binding of various monoamines, commonly 
in addition to endocrine and psychoneuroimmunological 
modulation[20]. Some medicinal plants with antidepressant 
activity such as H. perforatum, Crocus sativus (saffron) 
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(C. sativus) and Rhodiola rosea (R. rosea) (roseroot), offer 
promising results for the treatment of depression via 
known psychopharmacological actions such as inhibition 
of monoamine re-uptake (noradrenaline, serotonin and 
dopamine), monoamine oxidase inhibition, sensitization 
and enhancement of serotonin receptors binding, or 
neuroendocrine modulation[20]. Other suggested effects 
include GABAergic effects, opioid and cannabinoid system 
effects[21].
   Some herbal medicines, such as R. rosea and C. sativus, 
with mood elevating effects also display anxiolytic activity. 
This may be due to modulation of neurological pathways 
(GABAergic, serotonergic, and noradrenergic systems) that 
have both antidepressant and anxiolytic effects. This may 
also be due to inter-relation effects. Hence, following 
depression treatment, anxiety may also be reduced[22].
   Several herbal medicines have shown antidepressant 
activity in preclinical and clinical trials. The most important 
of these, having clinical trials, are detailed in Table 1 and 
the others which mostly have preclinical trials along with 
their components are summarized in Table 2.
   In a recent meta-analysis of randomized controlled trials, 
compared with selective serotonin reuptake inhibitors, 
H. perforatum yielded a significant difference in favor 
of H. perforatum over conventional antidepressants for 
withdrawal. A recent study involving 426 responders which 
were assessed for remission rates after continuation of 26 
weeks consumption of 300 mg H. perforatum, three times a 
day, or placebo, revealed a relapse rate for completers of 
18% compared to 26% for placebo.
   The tolerability of H. perforatum has been shown to be 
better than some synthetic antidepressants. Comparative 
studies between H. perforatum extract and paroxetine, 
revealed 10 to 39 fold higher adverse events rate for 
paroxetine. It should be noted that high-dose of hyperforin 
extracts (10 mg/d) causes CYP3A induction, however, 
4 mg/d of hyperforin extracts showed no significant effect 
on this enzyme[62].
   Two trials using 60 mg-90 mg of C. sativus extract showed 
significant improvement of depression over placebo[63]. 
Equivalent effects occurred in three clinical trials 
comparing C. sativus with imipramine and fluoxetine[64].
   These results seem to be encouraging, however, the 
shortage of trials lengths (4-6 weeks), smallness of sample 
sizes (n=30-45) are limitations which exist in confirming the 
efficacy potential of these compounds.
Table 1
Mechanisms of action and clinical applications of herbal antidepressants.
Plants Effects and possible mechanisms Clinical use Major active 
component
Reference
Echium amoenum (borage) Antidepressant, anxiolytic effects (unknown mechanism) Anxiety depression Rosmarinic acid 
Thesinine
[23]




Anxiety depression Safranal [24-26]
H. perforatum (St John’s wort) Dopaminergic activity
Serotonin, dopamine, norepinephrine re-uptake inhibition
Decreased degradation of neurochemicals
Increased binding/sensitivity to 5-HT1A,B
Glutamate neuronal release inhibition
Neuroendocrine modulation











Panax ginseng (Korean ginseng) HPA-axis modulation
Dopamine, norepinephrine and serotonin modulation
Anti-inflammatory and antioxidant activities







Albizia julibrissin (mimosa) 5-HT1a and 5-HT2c receptor binding affinity
Antidepressant, anxiolytic effects





R. rosea (roseroot) Monoamine oxidase A inhibition
Monoamine modulation (5-HT)
Anti-anxiety
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   C. sativus is also a promising antidepressant. However, 
there is only one clinical evaluating Echium amoenum in 
the treatment of depression. Results revealed that the herb 
was superior to placebo in reducing depression four weeks 
after drug consumption, with no significant anxiolytic 
activity[65].
   A clinical trial comparing Lavandula spp. with 
imipramine and the combination revealed that Lavandula 
officinalis was not as effective as imipramine, and their 
combination was more effective than imipramine alone, 
indicating a possible synergistic effect.
   A three-arm study using 340 mg/d and 680 mg/d R. rosea 
extract, in comparison to placebo in the treatment of mild-
moderate depression revealed a significant dose-dependent 
improvement in drug groups compared with placebo[66].
5. Clinical trials for anxiety
   Several plants with anxiolytic activity have been 
studied in clinical trials. A meta-analysis review of seven 
randomized controlled trial papers using Piper methysticum 
(P. methysticum) showed a significant reduction in 
comparison to placebo control group[67]. Another study on 
P. methysticum revealed a similar results, however, there 
are other studies showing no positive results[68-70].
   A clinical trial revealed that acute administration of 
Scutellaria lateriflora attenuated anxiety[71]. A pilot clinical 
Table 2
Anxiolicic and antidepressant plants and their components.
Scientific name Family name Biologic substances Reference
Achillea millefolium Asteraceae Essential oil, polyphenolic compounds, some species of flavons, sesquiterpene, lactones, betaine, 
acetylene compounds, resin, tannin, achillion, phosphate, nitrate, potassium salts, organic acids
[40]
Cassia fistula Fabaceae Sterols, flavonoids, anthraquinones, diterpenoids, three terpenoid, catechin, furfural, chrysophanol [41]
Citrus aurantium Rutaceae Hesperidin, neohesperidin, doxepin, apigenin [42]
C. sativus L. Iridaceae Crocin, crocetin, picrocrocin, safranal [43]
Dracocephalu polychaetum 
bornum
Lamiaceae Terpene, tannin and phenolic acids, geraniol, geranyl acetate, noural and rosmarinic and caffeic 
acids, cinnamic acid derivations, tannin and three terpenes like oleanolic acid and acacetin
[44]
Foeniculum vulgare Apiaceae Palmitic acid, oleic acid, linolenic acid, petroselinic acid [45]
Humulus lupulus Cannebinaceae Humulus (HOPS) [46]
Lavandula angustifolia Mill. Labiatae Linalool acetate, linalil-acetat, sinoel, nerol, perneol, camarines, tannins, flavonoids [47]
Matricaria chamomilla Asteraceae Terpenoid oil essences (azlon, chamazulene, oxide flavonoids), bisabolol, a and b sesquiterpenes 
(apigenin, chrysene, luteolin, quercetin), coumarins (umbelliferone), cycloserine and mucilages, 
salts, polysaccharides, tannin and fatty acids
[48]
M. officinalis Lamiaceae Citral, geraniol, linalool, citronellal, caffeic acid, anethole, terpineol-4, carvacrol-4, piperitone, 
eugenol, acid rosemary, phenolic acids and flavonoid, carnosic acid, linoleic acid, ursolic acid, 
rosmarinic acid
[49]
Mentha piperita Lamiaceae Acetaldehyde, amyl alcohol, menthyl esters, pinene, phellandrene, cadinen, pulegone, dimethyl 
sulfide, alpha-pinene, sabinene, ocimene, gama-terpinen, citronellol
[44]
Nardostachys jatamansi Valerianceae Isovaleric, valepotriate, sesquiterpenes acid [50]
Ocimum basilicum Lamiaceae Thujone, myrcene, linalool, geraniol caryophyllene, carrone, ursolic acid, apigenin, farnesol 
fenchone-pinene, cis-ocimene, trans-ocimene, camphor, eugenol, methyl-eugenol, α-farnese, 
α-bisabolene, D-germacrene, cineole
[51]
P. incarnata Passifloraceae Vitexin, iso-vitexin, passiflorin, harman, limonene, cumene, α-pinene [50]
Peganum harmala Nitrariaceae Norharmalin, harmin, harmaline and harmal [51]
Primula vulgaris Primulaceae Gamma-linolenic, linolenic acid [52]
Prunus amygdalus Rosaceae a-Linolenic acid, eicosapentaenoic acid, oleic acid and docosahexaenoic acid [53]
Rosa spp. Rosaceae Geraniol, citronellol, linalool, stearoptene [54]
Scrophularia striata Scrophulariaceae Phenolic, flavonoid and flavonolic compounds, cinnamic acid, isorhamnetin-3-o-rutinoside, 
quercetin, phenylpropanoid glycoside, nepitrin, acteoside
[55]
Silybum marianum L. Asteraceae Cilimarine [56]
Spinacia oleracea Amaranthaceae Acid linoleic, aid palmetic folic acid, saponin, lecithin, hexa acid linoleic, carotene, lycopene, 
coumaric acid, nucleoside purine, rubiscolin
[57]
Stachys lavandulifolia Laminacea Phenylethanol, terpenoid, flavonoid, myrcene, α-pinene, γ-muurolene [58]
Tilia platyphyllos Scop. Tiliaceae Different flavonoids like tiliroside, quercetin, isoquercetin, hyperoside and different amino acids 
like alanine, cysteine and cystine
[59]
Vitex agnus Verbenaceae Phytoestrogen [60]
Vitex agnus-castus Verbenaceae Sabinene, pinene, sesquiterpene, chrysophanol, aucubin [61]
Passiflora incarnata: P. incarnata; Melissa officinalis: M. officinalis.
Kourosh Saki et al./Asian Pac J Trop Med 2014; 7(Suppl 1): S34-S42S38
trial revealed equivocal efficacy to oxazepam (30 mg/d) P. 
incanata extract in reduction of anxiety, with neglectable 
side effects[72].
   An acute study using P. incanata for pre-surgical anxiety 
showed a significant reduction of anxiety. Toxicological 
study of P. incanata also revealed no evidence of safety 
concerns with this herb[73].
   A clinical trial using a flexible dose of Matricaria 
recutita revealed a significant effect in favour of the 
plant intervention, with no significant adverse effects 
in Matricaria recutita group, even with higher doses[74]. 
Ginkgo biloba (ginkgo) extract (480 mg/d or 240 mg/d) in 
patients with anxiety, also revealed a significant dose-
dependent reduction[75].
   H. perforatum has been shown to reduce anxiety in long 
term drug usage, with low level of side effects[76].
   In social phobia, a clinical trial exists using H. perforatum 
with flexible-dose of 600-1800 mg, in which no significant 
difference was found with placebo[78].
   Many anxiolytic plants reviewed had potential 
applications. These include improvement in mood (P. 
methysticum and M. officinalis), reduction in muscle tension 
or pain Eschscholzia californica (E. californica), hypnotic 
or sedative action for insomnia (Scutellaria lateriflora and 
P. incanata), or enhancement in cognition [Ginkgo biloba 
and Bacopa monniera (B. monniera)][21]. However, while the 
results are positive for a large group of medicinal plants, 
no definitive conclusion can be reached in some cases, as 
anxiety condition is notorious for high placebo response, 
and in some studies, no placebo arm has been employed.
6. Discussion
   There are growing preclinical and clinical trials, which 
show beneficial efficacy for herbal medicine to treat 
anxiety and depression. However, concerns exist over poor 
reporting of data in some clinical trials. The other issue is 
that many herbal medicines have not yet been rigorously 
tested in human clinical trials. Several herbal medicines 
such as B. monniera, E. californica, M. officinalis and 
Withania somnifera, mimosa (Albizia julibrissin), Zizyphus 
jujuba, M. officinalis and E. californica have been 
researched in preclinical models with positive results, 
however, these have not been yet studied as monotherapies 
in the treatment of psychiatric disorders. It should be noted 
that plants constituents undergo significant metabolism, 
being biotransformed into new chemical structures. Thus 
in vitro evidence cannot always be extrapolated to clinical 
efficacy in humans. Therefore, in this study we tried to 
mostly present clinical evidence of efficacies.
   It should be noted that some medicinal plants reviewed 
in this paper other than being used in modern practice to 
treat anxiety and depression, are used for other complex 
conditions. For example, E. californica is used for insomnia 
and pain[79], B. monniera for treatment of cognitive 
deficits[80], and M. officinalis for gastrointestinal complaints 
such as dyspepsia[81].
   The difference in bioequivalence of preparations used in 
the clinical trials should be taken in consideration. This 
matter is important when the results of different clinical 
studies are not consistent.
   Clinical or preclinical evaluation of medicinal plants is a 
complicated task. For example, the chemical composition 
of herbal preparations depends on many factors, such 
as environmental and genetic differences, harvest time, 
exposure to airborne vectors, soil quality, differences in 
plant parts used, and preparation methods. Consequently, 
it is difficult to produce standardized extracts with 
reproducible chemical composition. While preclinical 
studies of main active constituents are helpful, the evidence 
cannot guarantee the same efficacy of total extract in 
replicated batches[82].
   It should be noted that stress is not considered as 
disorder, but when stressors are continuous over a period 
of time, anxiety and depression can arise affecting largely 
on mood. The stress causes abnormal accumulation of free 
radicals which are the key factors in induction of various 
complications such as diabetes[83,84], atherosclerosis[85,86], 
cardiovascular diseases[87,88], neurological disorders[89,90]
and cancer[91,92], other than anxiety and depression. These 
conditions may cause many changes, including alterations 
in redox state[93,94].
   It has been revealed that stressed individuals have less 
levels of antioxidants in their blood serum than those who 
were not suffering from anxiety or depression.
   Furthermore, the supplementation with vitamins high 
in antioxidants (A, C, and E) has had a positive impact on 
severity of symptoms reported. Therefore, each of the plants 
reviewed here has its own mechanism of action, however, 
most of medicinal plants possess antioxidant activity[95-
98]. Medicinal plants have been shown to alleviate stress 
induced diseases such as diabetes[99,100], cancer[101,102], 
infection[103,104] and gastrointestinal disorders[105,106]. 
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Therefore, their effects on anxiety and depression, at least 
in part, might be due to their antioxidant activities.
   In conclusion, while medicinal plants reviewed in this 
paper are encouraging for the treatment of anxiety and 
depression, further research utilizing robust methodology, 
the use of biotechnologies to ensure bioequivalence of 
product and good manufacturing practice is still required to 
promote more confidence.
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